Page 258 - Read Online

Salvador M, Goncalves CA, Kapczinski F. Increased oxidative stress Disord 2014;172C: 300‑6.
and DNA damage in bipolar disorder: a twin‑case report. Prog 24. Uchida M, Serra G, Zayas L, Kenworthy T, Faraone SV, Biederman J.
Neuropsychopharmacol Biol Psychiatry 2007;31:283‑5. Can unipolar and bipolar pediatric major depression be
7. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S. differentiated from each other? A systematic review of cross‑sectional
Effect of treatment on serum brain‑derived neurotrophic factor studies examining differences in unipolar and bipolar depression.
levels in depressed patients. Eur Arch Psychiatry Clin Neurosci J Affect Disord 2015;176:1‑7.
2005;255:381‑6. 25. Duffy A. The early natural history of bipolar disorder: what we
8. de Sousa RT, van de Bilt MT, Diniz BS, Ladeira RB, Portela LV, have learned from longitudinal high‑risk research. Can J Psychiatry
Souza DO, Forlenza OV, Gattaz WF, Machado‑Vieira R. Lithium 2010;55:477‑85.
increases plasma brain‑derived neurotrophic factor in acute bipolar 26. Mesman E, Hillegers MH, Ambree O, Arolt V, Nolen WA,
mania: a preliminary 4‑week study. Neurosci Lett 2011;494:54‑6. Drexhage HA. Monocyte activation, brain‑derived neurotrophic
9. Tramontina JF, Andreazza AC, Kauer‑Sant’anna M, Stertz L, Goi J, factor (BDNF), and S100B in bipolar offspring: a follow‑up study
Chiarani F, Kapczinski F. Brain‑derived neurotrophic factor serum from adolescence into adulthood. Bipolar Disord 2015;17:39‑49.
levels before and after treatment for acute mania. Neurosci Lett 27. Gabbay V, Klein RG, Alonso CM, Babb JS, Nishawala M, De
2009;452:111‑3. Jesus G, Hirsch GS, Hottinger‑Blanc PM, Gonzalez CJ. Immune
10. Kauer‑Sant’Anna M, Kapczinski F, Andreazza AC, Bond DJ, system dysregulation in adolescent major depressive disorder.
Lam RW, Young LT, Yatham LN. Brain‑derived neurotrophic factor J Affect Disord 2009;115:177‑82.
and inflammatory markers in patients with early‑vs. late‑stage bipolar 28. Pandey GN, Rizavi HS, Ren X, Fareed J, Hoppensteadt DA,
disorder. Int J Neuropsychopharmacol 2009;12:447‑58. Roberts RC, Conley RR, Dwivedi Y. Proinflammatory cytokines in
11. Sussulini A, Dihazi H, Banzato CE, Arruda MA, Stuhmer W, the prefrontal cortex of teenage suicide victims. J Psychiatry Res
Ehrenreich H, Jahn O, Kratzin HD. Apolipoprotein A‑I as a candidate 2012;46:57‑63.
serum marker for the response to lithium treatment in bipolar 29. Goldstein BI, Collinger KA, Lotrich F, Marsland AL, Gill MK,
disorder. Proteomics 2011;11:261‑9. Axelson DA, Birmaher B. Preliminary findings regarding
12. Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and proinflammatory markers and brain‑derived neurotrophic factor
mortality in bipolar disorder. Ann Clin Psychiatry 2011;23:40‑7. among adolescents with bipolar spectrum disorders. J Child Adolesc
13. Leboyer M, Soreca I, Scott J, Frye M, Henry C, Tamouza R, Psychopharmacol 2011;21:479‑84.
Kupfer DJ. Can bipolar disorder be viewed as a multi‑system 30. Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello N.
inflammatory disease? J Affect Disord 2012;141:1‑10. Shortened onset of action of antidepressants in major depression
14. Herberth M, Koethe D, Levin Y, Schwarz E, Krzyszton ND, using acetylsalicylic acid augmentation: a pilot open‑label study. Int
Schoeffmann S, Ruh H, Rahmoune H, Kranaster L, Schoenborn T, Clin Psychopharmacol 2006;21:227‑31.
Leweke MF, Guest PC, Bahn S. Peripheral profiling analysis for 31. Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A,
bipolar disorder reveals markers associated with reduced cell Goldstein‑Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N,
survival. Proteomics 2011;11:94‑105. Moller HJ, Arolt V, Riedel M. The cyclooxygenase‑2 inhibitor
15. Brietzke E, Stertz L, Fernandes BS, Kauer‑Sant’anna M, celecoxib has therapeutic effects in major depression: results of a
Mascarenhas M, Escosteguy Vargas A, Chies JA, Kapczinski F. double‑blind, randomized, placebo controlled, add‑on pilot study
Comparison of cytokine levels in depressed, manic and euthymic to reboxetine. Mol Psychiatry 2006;11:680‑4.
patients with bipolar disorder. J Affect Disord 2009;116:214‑7. 32. Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta‑Soares GB,
16. Kim JW, Szigethy EM, Melhem NM, Saghafi EM, Brent DA. Frey BN, Bowden CL, Soares JC. Celecoxib as an adjunct in the
Inflammatory markers and the pathogenesis of pediatric depression treatment of depressive or mixed episodes of bipolar disorder:
and suicide: a systematic review of the literature. J Clin Psychiatry a double‑blind, randomized, placebo‑controlled study. Hum
2014;75:1242‑53. Psychopharmacol 2008;23:87‑94.
17. Kim YK, Jung HG, Myint AM, Kim H, Park SH. Imbalance between 33. Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P,
pro‑inflammatory and anti‑inflammatory cytokines in bipolar Drake DF, Haroon E, Miller AH. A randomized controlled trial of the
disorder. J Affect Disord 2007;104:91‑5. tumor necrosis factor antagonist infliximab for treatment‑resistant
18. O’Brien SM, Scully P, Scott LV, Dinan TG. Cytokine profiles in depression: the role of baseline inflammatory biomarkers. JAMA
bipolar affective disorder: focus on acutely ill patients. J Affect Disord Psychiatry 2013;70:31‑41.
2006;90:263‑7. 34. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D,
19. de Gonzalo‑Calvo D, Neitzert K, Fernandez M, Vega‑Naredo I, Peet M, Keck PE, Jr., Marangell LB, Richardson AJ, Lake J, Stoll AL.
Caballero B, Garcia‑Macia M, Suarez FM, Rodriguez‑Colunga MJ, Omega‑3 fatty acids: evidence basis for treatment and future research
Solano JJ, Coto‑Montes A. Differential inflammatory responses in in psychiatry. J Clin Psychiatry 2006;67:1954‑67.
aging and disease: TNF‑alpha and IL‑6 as possible biomarkers. Free 35. Barzman D, Eliassen J, McNamara R, Abonia P, Mossman D,
Radic Biol Med 2010;49:733‑7. Durling M, Adler C, DelBello M, Lin PI. Correlations of inflammatory
20. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, gene pathways, corticolimbic functional activities, and aggression
Yucel M, Gama CS, Dodd S, Dean B, Magalhaes PV, Amminger P, in pediatric bipolar disorder: a preliminary study. Psychiatry Res
McGorry P, Malhi GS. Pathways underlying neuroprogression 2014;224:107‑11.
in bipolar disorder: focus on inflammation, oxidative stress and 36. Su SC, Sun MT, Wen MJ, Lin CJ, Chen YC, Hung YJ. Brain‑derived
neurotrophic factors. Neurosci Biobehav Rev 2011;35:804‑17. neurotrophic factor, adiponectin, and proinflammatory markers in
21. Merikangas KR, Cui L, Kattan G, Carlson GA, Youngstrom EA, various subtypes of depression in young men. Int J Psychiatry Med
Angst J. Mania with and without depression in a community sample 2011;42:211‑26.
of US adolescents. Arch Gen Psychiatry 2012;69:943‑51. 37. Pandey GN, Rizavi HS, Dwivedi Y, Pavuluri MN. Brain‑derived
22. Birmaher B, Axelson D, Goldstein B, Strober M, Gill MK, neurotrophic factor gene expression in pediatric bipolar disorder:
Hunt J, Houck P, Ha W, Iyengar S, Kim E, Yen S, Hower H, effects of treatment and clinical response. J Am Acad Child Adolesc
Esposito‑Smythers C, Goldstein T, Ryan N, Keller M. Four‑year Psychiatry 2008;47:1077‑85.
longitudinal course of children and adolescents with bipolar spectrum 38. Lagopoulos J, Hermens DF, Tobias‑Webb J, Duffy S, Naismith SL,
disorders: the Course and Outcome of Bipolar Youth (COBY) study. White D, Scott E, Hickie IB. In vivo glutathione levels in young
Am J Psychiatry 2009;166:795‑804. persons with bipolar disorder: a magnetic resonance spectroscopy
23. Uchida M, Serra G, Zayas L, Kenworthy T, Hughes B, Koster A, study. J Psychiatr Res 2013;47:412‑7.
Faraone SV, Biederman J. Can manic switches be predicted in 39. Chitty KM, Lagopoulos J, Hickie IB, Hermens DF. Risky alcohol use
pediatric major depression? A systematic literature review. J Affect in young persons with emerging bipolar disorder is associated with

250 Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015